Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
Prostate cancer (PC) stratification needs new prognostic tools to reduce overtreatment. Phosphatase of regenerating liver (PRL-3) is a phosphatase found at high levels in several cancer types, where its expression is associated with survival. A recent PC cell line study has shown it to be involved i...
Main Authors: | Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy Bremnes, Magne Børset, Lill-Tove Busund, Tobias Slørdahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5708709?pdf=render |
Similar Items
-
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
by: Magnus Aassved Hjort, et al.
Published: (2018-04-01) -
Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
by: Christian Melbø-Jørgensen, et al.
Published: (2014-01-01) -
High progesterone receptor expression in prostate cancer is associated with clinical failure.
by: Thea Grindstad, et al.
Published: (2015-01-01) -
Phosphatase of regenerating liver-3 (PRL-3) associated proteins
by: Chang Chia-Liang, et al.
Published: (2004) -
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
by: Mehrdad Rakaee, et al.
Published: (2019-03-01)